Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma

Histology and Histopathology

Volumn 27, Issue 5, 2012, Pages 601-607

  Abou Asa, S ^a,b   Murai, A ^a   Murakami, M ^a   Hoshino, Y ^a   Mori, T ^a   Maruo, K ^a   Khater, A ^b   El Sawak, A ^b   Abd El Aziz, E ^b   Yanai, T ^a   Sakai, H ^a  

^a GIFU UNIVERSITY   (Japan)

^b KAFRELSHEIKH UNIVERSITY   (Egypt)

Author keywords

Dog; Hemangiosarcoma; Immunohistochemistry; PDGF receptors; PDGF BB

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET-DERIVED GROWTH FACTOR BB;

ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; FEMALE; HEMANGIOMA; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; SKIN TUMOR;

ANIMALS; DOG DISEASES; DOGS; FEMALE; HEMANGIOMA; HEMANGIOSARCOMA; IMMUNOHISTOCHEMISTRY; MALE; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SKIN NEOPLASMS;

CANIS FAMILIARIS;

EID: 84859307623     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bertazzolo W., Dellorco M., Benfanti U., Ghisteni G.,. Caniatti M., Masserdotti C., Antoniazzi E., Crippa L. and Roccabianca P. (2005). Canine angiosarcoma: cytologic, histologic, and immunohistochemical correlations. Vet. Clin. Pathol. 34, 28-34.
2. Borzacchiello G., Russo V., Gentile F., Roperto F., Venuti A., Nitsch L., Campo M.S. and Roperto S. (2006).Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor b receptor in naturally occurring bovine urinary bladder tumours. Oncogene 25, 1251-1260.
3. Brown N.O., Patnaik A.K. and MacEwen E.G. (1985). Canine hemangiosarcoma: retrospective analysis of 104 cases. J. Am. Vet. Med. Assoc. 186, 56-58.
4. Clifford C.A., Mackin A.J. and Henry C. J. (2000). Treatment of canine hemangiosarcoma: and beyond. J. Vet. Intern. Med. 14, 479-485.
5. Dalla-Favera R., Gallo R.C., Giallongo A. and Croce C.M. (1982). Chromosomal localization of the human homolog (c-sis) of the simian sarcoma virus onc gene. Science 218, 686-688.
6. De Marchis F., Ribatti D., Giampietri C., Lentini A., Faraone D., Scoccianti M., Capogrossi M.C. and Facchiano A. (2002) Plateletderived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor. Blood 99, 2045-2053.
7. DiMaio D., Lai C.C. and Mattoon D. (2000). The platelet-derived growth factor beta receptor as a target of the bovine papillomavirus E5 protein. Cytokine Growth Factor. Rev. 11,283-293.
8. Fayette J., Martin E., Piperno-Neumann S., Le Cesne A., Robert C., Bonvalot S., Ranchère D., Pouillart P., Coindre J.M. and Blay J.Y. (2007). Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann. Oncol. 18, 2030-2036.
9. Ferrara N. (1999). Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77, 527-543.
10. Ferrara N. (2001). Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell. Physiol. 280, 1358-1366.
11. Ferrara N. and Henzel W.J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851-858.
12. Ferrara N. and Kerbel K.S. (2005). Angiogenesis as a therapeutic target. Nature Insight 438, 967-974.
13. Folkman J. (1971). Tumor angiogenesis: therapeutic implications. New Engl. J. Med. 285, 1182-1186.
14. Fosmire S.P., Dickerson E.B., Scott A.M., Bianco S.R., Pettengill M.J., Meylemans H., Padilla M., Frazer-Abel A.A., Akhtar N., Getzy D.M., Wojcieszyn J., Breen M., Helfand S.C. and Modiano J.F. (2004). Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab. Invest. 84, 562-572.
15. Fury M.G., Antonescu C.R., Van Zee K.J., Brennan M.F. and Maki R.G. (2005). A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 11, 241-247.
16. Goldschmidt M.H. and Hendrick M.J. (2002). Tumors of the skin and soft tissue. In: Tumors in domestic animals. 4th ed, Meuten D.J. (ed). pp 45-119.
17. Hammer A.S., Couto C.G., Filppi J., Getzy D. and Shank K. (1991). Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J. Vet. Intern. Med. 5, 160-166.
18. Hashimoto M., Ohsawa M., Ohnishi A., Naka N., Hirota S., Kitamura Y. and Aozasa K. (1995). Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab. Invest. 73, 859-863.
19. Heldin C.H. and Westermark B. (1999). Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79, 1283-1300.
20. Kodama A., Sakai H., Matsuura S., Murakami M., Murai A., Mori T., Maruo K., Kimura T., Masegi T. and Yanai T. (2009). Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesisassociated homeobox genes. BMC Cancer 14, 9-363.
21. Koos B., Paulsson J., Jarvius M., Sanchez B.C., Wrede B., Mertsch S., Jeibmann A., Kruse A., Peters O., Wolff J.E., Galla H.J., Söderberg O., Paulus W., Ostman A. and Hasselblatt M. (2009). Plateletderived growth factor receptor expression and activation in choroid plexus tumors. Am. J. Pathol. 175, 1631-1637.
22. Kubo T., Piperdi S., Rosenblum J., Antonescu C.R., Chen W., Kim H., Huvos A.G., Sowers R., Meyers P.A., Healey J.H. and Gorlick R. (2008). Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma. Cancer 112, 2119-2129.
23. Lederle W., Linde N., Heusel J., Bzyl J., Woenne E.C., Zwick S., Skobe M., Fabian K., Fusenig N.E. and Mueller MM. (2010). Plateletderived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. Am. J. Pathol. 176, 981-994.
24. Levine R.A.(2002). Overexpression of the sis oncogene in a canine osteosarcoma cell line. Vet. Pathol. 39,411-412.
25. Liu Y.C., Chen S.C., Chang C., Leu C.M. and Hu C.P. (1996). Plateletderived growth factor is an autocrine stimulator for the growth and survival of human esophageal carcinoma cell lines. Exp. Cell. Res. 228, 206-211.
26. Lokker N.A., Sullivan C.M., Hollenbach S.J., Israel M.A. and Giese N.A. (2002). Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 62, 3729-3735.
27. Lucas D.R. (2009). Angiosarcoma, radiation-associated angiosarcoma, and atypical vascular lesion. Arch. Pathol. Lab. Med. 133, 1804-1809.
28. Magnusson P.U., Looman C., Ahgren A., Wu Y., Claesson-Welsh L. and Heuchel R.L. (2007). Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro. Arterioscler. Thromb. Vasc. Biol. 27, 2142-2149.
29. Mark R.J., Poen J.C., Tran L.M., Fu Y.S. and Juillard G.F. (1996). Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 77, 2400-2406,
30. Matei D., Kelich S., Cao L., Menning N., Emerson R.E., Rao J., Jeng M.H. and Sledge G.W. (2007). PDGF BB induces VEGF secretion in ovarian cancer. Cancer Biol. Ther. 12, 1951-1959.
31. McCarthy C.J., O'Brien G.C., Cummins R.J., Kay E.W. and Broe P.J. (2010). GIST with a twist-up regulation of PDGF-B resulting in metachronous gastrointestinal stromal tumor and dermatofibrosarcoma protuberans. J. Gastrointest. Surg. 14, 398-403.
32. Mobini N. (2009). Cutaneous epithelioid angiosarcoma: a neoplasm with potential pitfalls in diagnosis. J. Cutan. Pathol. 36, 362-369.
33. Nakagawa M., Naruko T., Ikura Y., Komatsu R., Iwasa Y., Kitabayashi C., Inoue T., Itoh A., Yoshiyama M. and Ueda M. (2010). A decline in platelet activation and inflammatory cell infiltration is associated with the phenotypic redifferentiation of neointimal smooth muscle cells after bare-metal stent implantation in acute coronary syndrome. J. Atheroscler. Thromb. 17, 675-687.
34. Oksanen A. (1978). Haemangiosarcoma in dogs. J. Comp. Pathol. 88, 585-595.
35. Petti L., Nilson L.A. and DiMaio D. (1991).Activation of the plateletderived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J. 10, 845-855.
36. Raica M. and Cimpean A.M. (2010). Platelet-derived growth factor (PDGF)/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy. Pharmaceuticals 3, 572-599.
37. Sabattini S. and Bettini G.J.(2009). Immunohistochemical analysis of heamangiosarcoma and heamangioma. J. Comp. Pathol. 140, 158-168.
38. Tamburini B.A., Trapp S., Phang T.L., Schappa J.T., Hunter L.E. and Modiano J.F. (2009). Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed. PLos ONE 20, 5549.
39. Thamm D.H. (2007). Hemangiosarcoma. In: Small animal clinical oncology. 4th ed. Withrow S.J. and Vail D.M. (eds). Saunders. St. Louis, Missouri, USA. pp 785-795.
40. Tokuyama W., Mikami T., Masuzawa M. and Okayasu I. (2010). Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGFC/ VEGFR-3 signaling in angiosarcoma of the scalp and face. Human Pathol. 41, 407-414.
41. Vassbotn F.S., Havnen O.K., Heldin C.H. and Holmsen H. (1994). Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor a-receptor. J. Biol. Chem. 269, 13874-13879.
42. Yonemaru K., Sakai H., Murakami M., Yanai T. and Masegi T. (2006). Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors. Vet. Pathol. 43, 971-980.
43. Zhang X., Rong T.H., Zhang Y., Long H., Fu J.H., Ling P., Zhang L.J., Yang M.T., Zeng C.G., Ma G.W., Su X.D., Li X.D., Wang J.Y., Wen Z.S. and Zhao J.M. (2006). Expression and significance of c-Kit and platelet-derived growth factor receptor-beta (PDGFR-beta) in esophageal carcinoma. Ai Zheng 25,92-95.